We are live on ! Find out more
VIVS

VivoSim Labs

38 hedge funds and large institutions have $2.64M invested in VivoSim Labs in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.13% less ownership

Funds ownership: 1.92%1.79% (-0.13%)

3% less funds holding

Funds holding: 3938 (-1)

35% less capital invested

Capital invested by funds: $4.07M → $2.64M (-$1.43M)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
12
Closed
4
Calls
Puts
Net Calls
Net Calls Change

VIVS Hedge Fund Activity: Q4 2022 in Review

38 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2022, worth a combined $2.64M — down 35% from $4.07M a quarter earlier.

Fund positioning in VIVS was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 12 trimmed.

The largest buyer was Rockefeller Capital Management, opening a new position worth an estimated $840. The largest seller was ARK Investment Management, cutting an estimated $101K.

  • 38 institutional investors held VivoSim Labs (VIVS) as of Q4 2022, down from 39 in Q3 2022.
  • Funds reported $2.64M of VivoSim Labs stock for Q4 2022, down 35% quarter-over-quarter.
  • 4 funds opened new VivoSim Labs positions in Q4 2022 and 4 closed out, a net change of 0 holders.
  • The largest VivoSim Labs buyer in Q4 2022 was Rockefeller Capital Management, an estimated $840 added.
  • The largest VivoSim Labs seller in Q4 2022 was ARK Investment Management, an estimated $101K sold.

Based on aggregated 13F filings for Q4 2022.